Andrew Gazdecki: From Bizness Apps to Acquire.com – Inside Startup Exits and Building Founder-Friendly M&A

Andrew Gazdecki: From Bizness Apps to Acquire...

Up next

Early-Stage Biotech Investing: Inside the Mind of Yaniv Sneor

Ever wondered what it takes to invest in the cutting-edge of biotech? In this episode, we sit down with Yaniv Sneor, a serial entrepreneur turned life science angel investor, to explore the world of early-stage biotech investing.From founding and scaling companies to building a n ...  Show more

Jordan Fliegel : From Pro Basketball to Startup Exits, Ex-Techstars MD, and Now Backing Acquisition Entrepreneurs

Jordan Fliegel: (Co-CEO of Shareholder Ventures, 5x Founder, Ex-Techstars MD) unpacks his journey from professional basketball benchwarmer to serial entrepreneur—and why he’s now helping others **buy profitable businesses** instead of starting them. **🗝️ HIGHLIGHTS YOU CAN’T MIS ...  Show more

Recommended Episodes

Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
In Good Company with Nicolai Tangen

Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, ...  Show more

Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
In Good Company with Nicolai Tangen

Nicolai Tangen meets with David Ricks, CEO of Eli Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is Eli Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original ...

  Show more

Making money in biotech stocks
Investing Experts

How to trade and invest in the biotech space with ROTY Biotech Community's Jonathan Faison (0:35). Making money in biotech (5:40). Managing sector risk (9:20). Geron - a stock he never thought he'd own (17:10).Show Notes:Finding Winners In Biotech, Probably The Riskiest SectorSyn ...  Show more

165. Biotech Investment Banking 101 Feat Sonia Gupta of Goldman Sachs
The Wall Street Skinny

Send us a text

In this episode, we sit down with Sonia Gupta, Partner and Co-Head of Biotech Investment Banking at Goldman Sachs. Sonia walks us through her unique journey—from ...

  Show more